Literature DB >> 8723745

Hepatic drug-metabolizing activities in rats after 14 days of oral administration of the human immunodeficiency virus-type 1 protease inhibitor ritonavir (ABT-538).

G N Kumar1, B Grabowski, R Lee, J F Denissen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8723745

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN： 0090-9556            Impact factor:   3.922


× No keyword cloud information.
  4 in total

1.  Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers.

Authors:  D Ouellet; A Hsu; J Qian; C S Locke; C J Eason; J H Cavanaugh; J M Leonard; G R Granneman
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

Review 2.  Ritonavir.

Authors:  A P Lea; D Faulds
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

Review 3.  Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents.

Authors:  A Hsu; G R Granneman; R J Bertz
Journal:  Clin Pharmacokinet       Date:  1998-10       Impact factor: 6.447

4.  Multidose pharmacokinetics of ritonavir and zidovudine in human immunodeficiency virus-infected patients.

Authors:  A Cato; J Qian; A Hsu; B Levy; J Leonard; R Granneman
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.